Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 50 of 461 publications.

Launois R, Le Moine JG, Huynh MT, Boissier MC. Analyse de l'impact budgétaire de la prise en charge de la polyarthrite rhumatoïde en 1ère, 2ème et 3ème ligne de traitement, après échec d'un traitement de fond. Presented at the French Society of Rheumatology 24th Annual Congress; December 11, 2011. Paris, France.

Sherrill EH, Halpern M, Khan SB, Zhang J, Panjabi S. Single Pill Versus Free-Equivalent Combination Therapies for Hypertension: a Meta-analysis of Health Care Costs and Adherence. J Clin Hypertens (Greenwich). 2011 Dec 5;13(12):898-909. doi: 10.1111/j.1751-7176.2011.00550.x

Sherrill B, Halpern M, Khan S, Zhang J, Panjabi S. Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich). 2011 Dec 1;13(12):898-909.

Sherrill B, Sherif B, Amonkar MM, Maltzman J, O'Rourke L, Johnston S. Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib. Curr Med Res Opin. 2011 Dec 1;27(12):2245-52.

Oldenburg CE, Sy A, Srinivasan M, Toutain-Kidd CM, Mascarenhas J, Ravindran M, Rajaraman R, Esterberg EJ, Chidambaram JD, Acharya NR, Lietman TM, Zegans ME. Pre-existing blindness in a cohort of patients with bacterial keratitis. Br J Ophthalmol. 2011 Dec;95(11):1612-3. doi: 10.1136/bjophthalmol-2011-300270.

Wu Y, Amonkar MM, Sherrill BH, O'Shaughnessy J, Ellis C, Baselga J, Blackwell KL, Burstein HJ. Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer. Ann Oncol. 2011 Dec 1;22(12):2582-90.

Mobley LR, Subramanian S, Koschinsky J, Frech HE, Trantham LC, Anselin L. Managed care and the diffusion of endoscopy in fee-for-service Medicare. Health Serv Res. 2011 Dec;46(6pt1):1905-27. doi: 10.1111/j.1475-6773.2011.01301.x

Williams LK, Peterson EL, Wells K, Ahmedani BK, Kumar R, Burchard EG, Chowdhry VK, Favro D, Lanfear DE, Pladevall M. Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence. J Allergy Clin Immunol Pract. 2011 Dec 1;128(6):1185-91.

Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Joffe MM, Glynn RJ. Effects of adjusting for instrumental variables on bias and precision of effect estimates. Am J Epidemiol. 2011 Dec 1;174(11):1213-22.

Myers JA, Rassen JA, Gagne JJ, Huybrechts KF, Schneeweiss S, Rothman KJ, Glynn RJ. Myers et al. respond to "understanding bias amplification". Am J Epidemiol. 2011 Dec;174(11):1228-9.

Heilemann MV, Pieters HC, Kehoe P, Yang Q. Schema therapy, motivational interviewing, and collaborative-mapping as treatment for depression among low income, second generation Latinas. J Behav Ther Exp Psychiatry. 2011 Dec;42(4):473-80.

Phipatanakul W, Bailey A, Hoffman EB, Sheehan WJ, Lane JP, Baxi S, Rao D, Permaul P, Gaffin JM, Rogers CA, Muilenberg ML, Gold DR. The school inner-city asthma study: design, methods, and lessons learned. J Asthma. 2011 Dec;48(10):1007-14. doi: 10.3109/02770903.2011.624235

Gittelman M, Brown TM, Holm-Larsen T, Persson BE. Comparison of the impact of degarelix and leuprolide on the health-related quality of life of patients with prostate cancer: results of a 12-month phase III clinical trial. UroToday International Journal. 2011 Dec 1;4(6):Art. 81.

Crean S, Ward A, Mercaldi CJ, Collins JM, Cook MN, Baker NL. Regional estimates for prevalence of apolipoprotein E(APOE) E4 carriers (heterozygotes and homozygotes) among patients with Alzheimer's disease: a meta-analysis. Poster presented at the Alzheimer's Disease International; December 2011. London, England.

Varas-Lorenzo C, Riera-Guardia N, Calingaert B, Castellsague J, Pariente A, Scotti L, Sturkenboom M, Perez-Gutthann S. Stroke risk and NSAIDs: a systematic review of observational studies. Pharmacoepidemiol Drug Saf. 2011 Dec 1;20(12):1225-36.

Herring WL, Herrmann JW. A stochastic dynamic program for the single-day surgery scheduling problem. IIE Trans Healthc Syst Eng. 2011 Dec 1;1(4):213-25.

Ahern TP, Pedersen L, Svaerke C, Rothman KJ, Sorensen HT, Lash TL. The association between vitamin K antagonist therapy and site-specific cancer incidence estimated by using heart valve replacement as an instrumental variable. Am J Epidemiol. 2011 Dec 1;174(12):1382-90.

Ritchey ME. Defining the useful research data landscape. Poster presented at the FDA Public Workshop: Using Scientific Research Data to Support Pediatric Medical Device Claims; December 2011. Silver Spring, MD.

Ritchey ME. Medical devices post-approval: current practice in US. Poster presented at the IDEAL Workshop; December 2011. Silver Spring, MD.

Hong J, Reed C, Novick D, Haro JM, Aguado J. Clinical and economic consequences of medication non-adherence in the treatment of patients with a manic/mixed episode of bipolar disorder: results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) study. Psychiatry Research. 2011 Nov 30;190(1):110-4.

Trask PC, Mitra D, Iyer S, Candrilli SD, Kaye JA. Treatment response patterns and related prognostic indicators in chronic myeloid leukemia patients: a multi-country medical record review study. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):3131. doi: 10.1182/blood.V118.21.3131.3131

Zhou X, Wang J, Zhang J, Copley-Merriman K, Torigoe Y, Reyes C. Symptoms and toxicity of rituximab maintenance (R-M) versus observation (OBS) following rituximab plus chemotherapy in patients with follicular lymphoma. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):3661. doi: 10.1182/blood.V118.21.3661.3661

Sinha R, Byrtek M, DeJoubner NJ, Nooka AK, Taylor M, Cerhan JR, Ziemiecki RM. Examining the outcomes of watchful waiting (WW) among US patients with advanced stage follicular lymphoma (FL). Presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):775. doi: 10.1182/blood.V118.21.775.775

Henk HJ, Deeter R, Kaye JA, Becker LK, Legg JC, Rothman KJ. Effect of age on neutropenia-related hospitalization in Non-Hodgkin's lymphoma patients receiving myelosuppressive chemotherapy. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):2082. doi: 10.1182/blood.V118.21.2082.2082

Kiladjian J, Al-Ali H, Gisslinger H, Knoops L, Waltzman RJ, Mendelson E, Copley-Merriman K. Health-related quality of life and symptoms in myelofibrosis patients treated with ruxolitinib versus best available therapy. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):795. doi: 10.1182/blood.V118.21.795.795

Meyers JL, Yu YF, Davis KL. Medicare fee-for-service enrollees with acute myelogenous leukemia: an analysis of treatment patterns and patient survival. Poster presented at the 53rd American Society of Hematology (ASH) Annual Meeting and Exposition; December 2011. San Diego, CA. [abstract] Blood. 2011 Nov 18; 118(21):505. doi: 10.1182/blood.V118.21.505.505

Gonzalez J, Johnson R, Runken MC, Poulos C. Generalized healthy-time equivalents for migraine-treatment outcomes from choice-experiment trade-off preferences. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011.

Bennett L, Zhao Z, Barber B, Zhou X, Peeters M, Zhang J, Xu F, Wiezorek J, Douillard JY. Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment. Poster presented at the American Society of Clinical Oncology Annual Meeting; June 2011. Chicago, IL. [abstract] J Clin Oncol. 2011 Nov 8; 29(15 Suppl):e19500. doi: 10.1038/bjc.2011.409.

Stull DE, Houghton KF, Kulich K. Innovative methods for demonstrating value for pharmaceutical products: rethinking data analysis with implications for study design and personalized medicine. Presented at the International Society for Pharmacoeconomics and Outcomes Research; November 5, 2011. Madrid, Spain.

Stull DE, Houghton KF, Filonenko A. Study heterogeneity in treatment response in women with idiopathic menorrhagia treated with levonorgestrel-releasing intrauterine system (LGN-IUS): application of innovative methods to identify differential response. Presented at the 2011 ISPOR 14th Annual European Congress; November 5, 2011. Madrid, Spain.

Ribera A, Ferreira-Gonzalez I, Marsal JR, Cascant P, Permanyer-Miralda G, Abdul-Jawad O, Inigo-Garcia LA, Guarinos-Oltra J, Cequier A, Goicolea-Guemez L, Garcia-Del-Blanco B, Marti G, Garcia-Dorado D. Prognostic value of an abnormal ankle-brachial index in patients receiving drug-eluting stents. Am J Cardiol. 2011 Nov 1;108(9):1225-31. doi: 10.1016/j.amjcard.2011.06.036

Wohlgenant KC, Hersey JC, Arsenault JE, Kosa KM, Muth MK. Comprehensive review of consumer, producer, and retailer response to front-of-package and shelf nutrition labeling systems. Poster presented at the APHA 139th Annual Meeting and Exposition; November 1, 2011. Washington, DC.

McKenna SP, Wilburn J, Crawford SR, Aryamanesh M, Twiss J. New developments in the Ankylosing Spondylitis Quality of Life (ASQOL) scale. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A314.

Domingo P, Hill A, Gostkorzewicz J, Brogan A. Comparative cost-effectiveness analysis between darunavir/r and other protease inhibitors in the treatment of HIV-1 infection in naïve patients in Spain. Poster presented at the Third National GESIDA Congress; November 2011. Seville, Spain. doi: 10.1016 / j.eimc.2012.11.001

Stull DE, Houghton K. Examining variability in depression among pre-retirees: innovative analytic methods applied to observational data. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A301.

Stull DE, Houghton KF, Gale R, Wiklund I, Capkun-Niggli G, Jones P. Application of innovative methods to identify and characterize differential responders in clinical trials of COPD: the use of mixture models. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A501-2.

Stull DE, Wiklund I, Gale R, Capkun-Niggli G, Houghton K, Jones P. Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD. Contemp Clin Trials. 2011 Nov 1;32(6):818-28.

Stull DE, Vanness D, Labrelli D, Filonenko A, Franke E, Wittrup-Jensen K. Assessment of country-level health-related quality of life (HRQL) outcomes and treatment effect of levonorgestrel-releasing intrauterine system (LNG-IUS) in women with idiopathic menorrhagia. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A406.

Palsgrove A, Houghton KF, Hareendran A, Schaefer M, Setyawan J, Mocarski M, Carson R, Make B. The development of the early morning symptoms of COPD instrument (EMSCI). Poster presented at the 2011 ISPOR 14th Annual European Congress; November 16, 2011. [abstract] Value Health. 2011 Nov; 14(7):A496-7.

Wilburn J, McKenna S, Crawford SR, Perry-Hinsley D, Bayat A. Determining the true impact of dupuytren's disease: a qualitative study. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A314-5.

Mitra D, Trask P, Iyer S, Candrilli S, Kaye J. A multi-country retrospective study of patient characteristics and treatment patterns in chronic myeloid leukemia. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 10, 2011. [abstract] Value Health. 2011 Nov; 14(7):A468.

Mohamed AF, Hauber AB, Neary MP. Patient benefit-risk preferences for targeted agents in the treatment of renal cell carcinoma. Pharmacoeconomics. 2011 Nov 1;29(11):977-88.

Mohamed AF, Johnson F, Hauber B, Lescrauwaet B, Saylan M. Do patients and physicians have similar preferences for chronic hepatitis b treatment outcomes in Turkey? Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A282.

Antela A, Llibre JM, Lopez Bernaldo De Quiros JC, Portilla J, Gallois A, Campbell A, Penafiel J, Brogan AJ, Talbird SE. HIV Treatment Cost-Effectiveness Study Group. An economic model to assess the cost-effectiveness of early treatment initiation for people with HIV infection in Spain. Poster presented at the Third National GESIDA Congress; November 2011. Seville, Spain.

Twiss J, McKenna SP, Bloch M, Bonney M. Patient and clinician perceived benefit of early consumption of famciclovir for the treatment of herpes outbreaks. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A266. doi: 10.1016/j.jval.2011.08.193

Ganderton L, Jenkins S, McKenna SP, Gain K, Fowler R, Twiss J, Gabbay E. Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population. Respirology. 2011 Nov;16(8):1235-40. doi: 10.1111/j.1440-1843.2011.02030.x

Candrilli SD, Bell CF, Davis KL. Recent trends in muscular dystrophy-related inpatient care among pediatric patients in the United States. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 2011. Madrid, Spain. [abstract] Value Health. 2011 Nov; 14(7):A320.

Earnshaw SR, McDade CL, Zanotti G, Farkouh R, Strutton D. Cost-effectiveness of 2+1 dosing of 13-valent pneumococcal conjugate vaccine compared with 2+1 dosing of 10-valent conjugate vaccine in preventing pneumococcal disease in Canada. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A275.

Arana A, Arellano F, Suissa S. Suicide-related events in patients treated with antiepileptic drugs: not an example of time-window bias [Comment]. Epidemiology. 2011 Nov;22(6):876-7.

Clark M, Hofmann A, Tabberer M, Martin S. Development and content validity of the COPD device preference questionnaire. Poster presented at the 2011 ISPOR 14th Annual European Congress; November 9, 2011. [abstract] Value Health. 2011 Nov; 14(7):A255.